It’s going to be a busy 4 days in Paris, with 166 late-breaking studies and nearly 2,000 clinical cases to be presented.
Coronary artery disease study shows similar mortality for CABG and PCI, but lower adverse events and revascularisation rates ...
The apparent sweet spot for cangrelor bridging, 0.75 mcg/kg/min, had been administered to just 22.5% of patients. It turned ...
No significant difference was observed in all-cause mortality at 10 years between PCI and CABG in patients with unprotected left main coronary artery disease (CAD) and no additional complex lesions, ...
The randomized PRO-TAVI trial showed that in patients with coronary artery disease undergoing transcatheter aortic valve implantation (TAVI), a deferred strategy, waiting to assess the need for ...
Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are the 2 revascularization modalities for patients with severe coronary artery disease. While CABG has often ...
Percutaneous coronary intervention for coronary chronic total occlusion is associated with a significant improvement in angina symptom scores compared with a placebo procedure. Percutaneous coronary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results